Transcatheter Embolization and Occlusion Devices Market

Transcatheter Embolization and Occlusion Devices Market (Product - Embolization Coils, Coiling-assist Devices, Embolization Particles, Flow Diverter Devices, Liquid Embolics, Accessories; Application - Peripheral Vascular Disease, Neurology, Oncology, Urology; End user - Hospitals, Ambulatory Surgical Centers, Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global transcatheter embolization and occlusion devices market for the historical period 2017–2018 and forecast period 2019–2027. Rise in prevalence of chronic diseases, technological advancements, increase in patient awareness and health care expenditure, and surge in need of treatment of complex diseases drive the global market during the forecast period.
  • According to the report, the global transcatheter embolization and occlusion devices market was valued at US$ 2,957.4 Mn in 2018 and is anticipated to expand at a CAGR of 7.8 % from 2019 to 2027. In terms of volume, the global transcatheter embolization devices were accounted at 73,92,954 units in 2018. 
fa global transcatheter embolization occlusion devices market

To know the scope of our report Get a Sample on Transcatheter Embolization and Occlusion Devices Market

Increase in Spectrum of Transcatheter Embolization in Gynecologic and Obstetric Indications: Key Drivers

  • Transcatheter embolization is a useful therapeutic option for a wide range of gynecologic and obstetric abnormalities. Transcatheter embolization procedures performed with the use of radiologic imaging for guidance are minimally invasive and could prevent surgery, thereby decreasing morbidity and mortality and conserving a patient’s future fertility potential.
  • Under experienced interventional radiologists and essential technical support, transcatheter embolization can be performed for the treatment of numerous lesions in the female pelvis, including obstetric-gynecologic hemorrhage, advanced-stage malignancy, ectopic pregnancy, and arteriovenous malformation. It can also be used to treat pelvic congestion syndrome and symptomatic uterine fibroids in women who have undergone appropriate screening. Global success rate of 85% and higher have been reported in women treated with embolization for uterine fibroids.

Get a glimpse of the in-depth analysis through our Report Brochure

Development of New Materials for Catheterization and Embolization Boost Market Growth

  • As new materials for catheterization and embolization are developed, to provide greater vascular occlusion with regard to clinical performance and lower the complication rates. Many new agents have appeared on the market in the past several years.
  • Liquid embolic agents under investigation are primarily targeted toward the treatment of aneurysms, AVMs, and HCC. The administration of currently available liquid embolic polymers, NBCA, Onyx, and PHIL are associated with the introduction of toxic compounds. Hence, several groups are investigating new in situ gelling polymer systems that avoid the use of toxic byproducts or solvents.
  • The number of flow-directed embolic materials is expanding. The microspheres are prepared using a suspension polymerization process of poly(lactide-co-glycolide)-block-poly(ethylene glycol) crosslinker and PEGMA monomer. Co-monomers methacrylic acid (MA) and 2-methylene-1,3-dioxepane (MDO) were integrated to refine its properties.

Post Embolization Syndrome to Hamper Market

  • Embolization is a useful technique in the therapeutic management of patients with vascular injuries caused by trauma, liver surgery, or percutaneous procedures. Such injuries are unusual; however, the presence of hemobilia or hemoperitoneum resulting from pseudoaneurysm or laceration of a blood vessel could put a patient critically at risk. Selective embolization of the injury provides excellent results as far as hemostasis is concerned (86%), although an associated morbidity of 58% has been described, which is basically connected with bile leakage, liver abscesses, and/or necrosis. Such lesions should, therefore, be treated on an individual basis, with full awareness of the possible consequences of a technique that is not risk-free.
  • The most common complication after embolization, the cause of which is still not properly understood, is the occurrence of fever, pain in the right hypochondrium, and a rise in transaminases. High temperature (< 38.5°C) may occur between 41% and 74% of cases and seems to be related to the presence of necrosis of the tumor and healthy tissue. Cytolysis (increase in transaminases), which has been observed in up to 93% of cases, is related to damage to healthy (noncancerous) hepatocytes.

Expanding operations in future? To get the perfect launch ask for a custom report 

Global Transcatheter Embolization and Occlusion Devices Market: Competitive Landscape

  • This report profiles major players in the global transcatheter embolization and occlusion devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global transcatheter embolization and occlusion devices market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global transcatheter embolization and occlusion devices market are
    • BTG plc
    • Boston Scientific Corporation
    • Medtronic plc
    • Penumbra, Inc.
    • Cook Medical
    • Edwards Lifesciences Corporation
    • Merit Medical Systems
    • Johnson & Johnson Services, Inc.
    • Pfizer, Inc.
    • Stryker Corporation
    • Terumo Corporation
    • Sirtex Medical Limited
    • Abbott Laboratories.

Global Transcatheter Embolization and Occlusion Devices Market: Key Developments

Key players in the global transcatheter embolization and occlusion devices market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global transcatheter embolization and occlusion devices market. A few expansion strategies adopted by players operating in the global transcatheter embolization and occlusion devices market are:

  • In October 2017, BTG plc announced the acquisition of Roxwood Medical, a manufacturer of advanced cardiovascular specialty catheters used in the treatment of patients with severe coronary and peripheral artery disease.
  • In October, 2017, Boston Scientific Corporation completed the acquisition of Apama Medical Inc. (Apama), a privately-held company developing the Apama Radiofrequency single-shot Balloon Catheter System for the treatment of atrial fibrillation.
  • In January 2017, Ethicon Endo-Surgery, Inc., a subsidiary of Johnson and Johnson, announced the acquisition of Megadyne Medical Products, Inc., a privately-held medical devices company that develops, manufactures, and markets electrosurgical tools used in operating rooms across the globe.

The report on the global transcatheter embolization and occlusion devices market discussed individual strategies, followed by company profiles of manufacturers of transcatheter embolization and occlusion devices. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global transcatheter embolization and occlusion devices market.

Global Transcatheter Embolization and Occlusion Devices Market - Segmentation

Product

Embolization Coils

Coiling Assist Devices

Embolization Particles

Flow Diverter Devices

Liquid Embolics

Accessories

Application

Peripheral Vascular Disease

Neurology

Oncology

Urology

Others

End-user

Hospitals

Ambulatory Surgical Centers

Clinics

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

What is the total market worth of transcatheter embolization and occlusion devices market?

The global transcatheter embolization and occlusion devices market was worth US$ 2,957.4 Mn and is projected to reach a value of US$ 5,799.8 Mn by the end of 2027

What is the anticipated CAGR of the transcatheter embolization and occlusion devices market in the forecast period?

Transcatheter embolization and occlusion devices market is anticipated to grow at a CAGR of 7.8% during the forecast period

Which region is expected to project the highest market share in the global transcatheter embolization and occlusion devices market?

North America accounted for a major share of the global transcatheter embolization and occlusion devices market

What are the key driving factors for the growth of the transcatheter embolization and occlusion devices market?

Transcatheter embolization and occlusion devices market is driven by increase in patient awareness and health care expenditure, and surge in need of treatment of complex diseases

Who are the key players in the global transcatheter embolization and occlusion devices market?

Key players in the global transcatheter embolization and occlusion devices market include BTG plc, Boston Scientific Corporation, Medtronic plc, Penumbra, Inc., Cook Medical, Edwards Lifesciences Corporation, Merit Medical Systems, Johnson & Johnson Services, Inc., Pfizer, Inc., Stryker Corporation, Terumo Corporation, Sirtex Medical Limited, and Abbott Laboratories

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Transcatheter Embolization and Occlusion Devices Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Transcatheter Embolization and Occlusion Devices Introduction

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast, 2017–2027

            4.4.1. Market Revenue (US$ Mn) and Volume (Units), Projection

    5. Key Insights

    6. Global Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast, by Product

        6.1. Introduction & Definition

            6.1.1. Key Findings / Developments

        6.2. Global Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2017–2027

            6.2.1. Embolization Coils

                6.2.1.1. Pushable

                6.2.1.2. Detachable

            6.2.2. Coiling-assist Devices

                6.2.2.1. Stent-assisted Coiling

                6.2.2.2. Balloon-assisted Coiling

            6.2.3. Embolization Particles

                6.2.3.1. Radioembolization Particles

                6.2.3.2. Microspheres

                6.2.3.3. Drug-eluting Beads

                6.2.3.4. Others

            6.2.4. Flow-diverting Devices

            6.2.5. Liquid Embolics

            6.2.6. Accessories

                6.2.6.1. Catheters

                6.2.6.2. Guide wires

                6.2.6.3. Others

        6.3. Global Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Product

    7. Global Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

            7.1.1. Key Findings / Developments

        7.2. Global Transcatheter Embolization and Occlusion Devices Market Value Forecast, by Application, 2017–2027

            7.2.1. Peripheral Vascular Disease

            7.2.2. Neurology

            7.2.3. Oncology

            7.2.4. Urology

            7.2.5. Others

        7.3. Global Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Application

    8. Global Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

            8.1.1. Key Findings / Developments

        8.2. Global Transcatheter Embolization and Occlusion Devices Market Value Forecast, by End-user, 2017–2027

            8.2.1. Hospitals

            8.2.2. Ambulatory Surgical Centers

            8.2.3. Clinics

        8.3. Global Transcatheter Embolization and Occlusion Devices Market Attractiveness, by End-user

    9. Global Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Global Transcatheter Embolization and Occlusion Devices Market Value Forecast, by Region

            9.2.1. North America 

            9.2.2. Europe 

            9.2.3. Asia Pacific 

            9.2.4. Latin America 

            9.2.5. Middle East & Africa 

        9.3. North America Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Region

    10. North America Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2017–2027

            10.2.1. Embolization Coils

                10.2.1.1. Pushable

                10.2.1.2. Detachable

            10.2.2. Coiling-assist Devices

                10.2.2.1. Stent-assisted Coiling

                10.2.2.2. Balloon-assisted Coiling

            10.2.3. Embolization Particles

                10.2.3.1. Radioembolization Particles

                10.2.3.2. Microspheres

                10.2.3.3. Drug-eluting Beads

                10.2.3.4. Others

            10.2.4. Flow-diverting Devices

            10.2.5. Liquid Embolics

            10.2.6. Accessories

                10.2.6.1. Catheters

                10.2.6.2. Guide wires

                10.2.6.3. Others

        10.3. North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

            10.3.1. Peripheral Vascular Disease

            10.3.2. Neurology

            10.3.3. Oncology

            10.3.4. Urology

            10.3.5. Others

        10.4. North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

            10.4.1. Hospitals

            10.4.2. Ambulatory Surgical Centers

            10.4.3. Clinics

        10.5. North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Country, 2017–2027

            10.5.1. U.S.

            10.5.2. Canada

        10.6. North America Transcatheter Embolization and Occlusion Devices Market Attractiveness Analysis 

            10.6.1. By Product

            10.6.2. By Application

            10.6.3. By End-user

            10.6.4. By Country

    11. Europe Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2017–2027

            11.2.1. Embolization Coils

                11.2.1.1. Pushable

                11.2.1.2. Detachable

            11.2.2. Coiling-assist Devices

                11.2.2.1. Stent-assisted Coiling

                11.2.2.2. Balloon-assisted Coiling

            11.2.3. Embolization Particles

                11.2.3.1. Radioembolization Particles

                11.2.3.2. Microspheres

                11.2.3.3. Drug-eluting Beads

                11.2.3.4. Others

            11.2.4. Flow-diverting Devices

            11.2.5. Liquid Embolics

            11.2.6. Accessories

                11.2.6.1. Catheters

                11.2.6.2. Guide wires

                11.2.6.3. Others

        11.3. Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

            11.3.1. Peripheral Vascular Disease

            11.3.2. Neurology

            11.3.3. Oncology

            11.3.4. Urology

            11.3.5. Others

        11.4. Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

            11.4.1. Hospitals

            11.4.2. Ambulatory Surgical Centers

            11.4.3. Clinics

        11.5. Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Country/Sub-region, 2017–2027

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. Rest of Europe 

        11.6. Europe Transcatheter Embolization and Occlusion Devices Market Attractiveness Analysis 

            11.6.1. By Product

            11.6.2. By Application

            11.6.3. By End-user

            11.6.4. By Country/Sub-region

    12. Asia Pacific Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2017–2027

            12.2.1. Embolization Coils

                12.2.1.1. Pushable

                12.2.1.2. Detachable

            12.2.2. Coiling-assist Devices

                12.2.2.1. Stent-assisted Coiling

                12.2.2.2. Balloon-assisted Coiling

            12.2.3. Embolization Particles

                12.2.3.1. Radioembolization Particles

                12.2.3.2. Microspheres

                12.2.3.3. Drug-eluting Beads

                12.2.3.4. Others

            12.2.4. Flow-diverting Devices

            12.2.5. Liquid Embolics

            12.2.6. Accessories

                12.2.6.1. Catheters

                12.2.6.2. Guide wires

                12.2.6.3. Others

        12.3. Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

            12.3.1. Peripheral Vascular Disease

            12.3.2. Neurology

            12.3.3. Oncology

            12.3.4. Urology

            12.3.5. Others

        12.4. Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

            12.4.1. Hospitals

            12.4.2. Ambulatory Surgical Centers

            12.4.3. Clinics

        12.5. Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Country/Sub-region, 2017–2027

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia 

            12.5.5. Rest of Asia Pacific 

        12.6. Asia Pacific Transcatheter Embolization and Occlusion Devices Market Attractiveness Analysis 

            12.6.1. By Product

            12.6.2. By Application

            12.6.3. By End-user

            12.6.4. By Country/Sub-region

    13. Latin America Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2017–2027

            13.2.1. Embolization Coils

                13.2.1.1. Pushable

                13.2.1.2. Detachable

            13.2.2. Coiling-assist Devices

                13.2.2.1. Stent-assisted Coiling

                13.2.2.2. Balloon-assisted Coiling

            13.2.3. Embolization Particles

                13.2.3.1. Radioembolization Particles

                13.2.3.2. Microspheres

                13.2.3.3. Drug-eluting Beads

                13.2.3.4. Others

            13.2.4. Flow-diverting Devices

            13.2.5. Liquid Embolics

            13.2.6. Accessories

                13.2.6.1. Catheters

                13.2.6.2. Guide wires

                13.2.6.3. Others

        13.3. Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

            13.3.1. Peripheral Vascular Disease

            13.3.2. Neurology

            13.3.3. Oncology

            13.3.4. Urology

            13.3.5. Others

        13.4. Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

            13.4.1. Hospitals

            13.4.2. Ambulatory Surgical Centers

            13.4.3. Clinics

        13.5. Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Country/Sub-region, 2017–2027

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America Latin America 

        13.6. Latin America Transcatheter Embolization and Occlusion Devices Market Attractiveness Analysis 

            13.6.1. By Product

            13.6.2. By Application

            13.6.3. End-user

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2017–2027

            14.2.1. Embolization Coils

                14.2.1.1. Pushable

                14.2.1.2. Detachable

            14.2.2. Coiling-assist Devices

                14.2.2.1. Stent-assisted Coiling

                14.2.2.2. Balloon-assisted Coiling

            14.2.3. Embolization Particles

                14.2.3.1. Radioembolization Particles

                14.2.3.2. Microspheres

                14.2.3.3. Drug-eluting Beads

                14.2.3.4. Others

            14.2.4. Flow-diverting Devices

            14.2.5. Liquid Embolics

            14.2.6. Accessories

                14.2.6.1. Catheters

                14.2.6.2. Guide wires

                14.2.6.3. Others

        14.3. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

            14.3.1. Peripheral Vascular Disease

            14.3.2. Neurology

            14.3.3. Oncology

            14.3.4. Urology

            14.3.5. Others

        14.4. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

            14.4.1. Hospitals

            14.4.2. Ambulatory Surgical Centers

            14.4.3. Clinics

        14.5. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Country/Sub-region, 2017–2027

            14.5.1. UAE

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa 

        14.6. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Attractiveness Analysis 

            14.6.1. By Product

            14.6.2. By Application

            14.6.3. End-user

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (by Tier and Size of companies)

        15.2. Competitive Market Ranking, by Company, 2018

        15.3. Company Profiles

            15.3.1. BTG plc

                15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.1.2. Growth Strategies

                15.3.1.3. SWOT Analysis

            15.3.2. Boston Scientific Corporation 

                15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.2.2. Growth Strategies

                15.3.2.3. SWOT Analysis

            15.3.3. Medtronic Plc 

                15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.3.2. Growth Strategies

                15.3.3.3. SWOT Analysis

            15.3.4. Penumbra, Inc. 

                15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.4.2. Growth Strategies

                15.3.4.3. SWOT Analysis

            15.3.5. Cook Medical

                15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.5.2. Growth Strategies

                15.3.5.3. SWOT Analysis

            15.3.6. Edwards Lifesciences Corporation 

                15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.6.2. Growth Strategies

                15.3.6.3. SWOT Analysis 

            15.3.7. Merit Medical Systems 

                15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.7.2. Growth Strategies

                15.3.7.3. SWOT Analysis

            15.3.8. Johnson & Johnson Services, Inc. 

                15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.8.2. Growth Strategies

                15.3.8.3. SWOT Analysis

            15.3.9. Pfizer, Inc.

                15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.9.2. Growth Strategies

                15.3.9.3. SWOT Analysis

            15.3.10. Stryker Corporation 

                15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.10.2. Growth Strategies

                15.3.10.3. SWOT Analysis

            15.3.11. Terumo Corporation

                15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.11.2. Growth Strategies

                15.3.11.3. SWOT Analysis

            15.3.12. Sirtex Medical Limited 

                15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.12.2. Growth Strategies

                15.3.12.3. SWOT Analysis

            15.3.13. Abbott Laboratories 

                15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.13.2. Growth Strategies

                15.3.13.3. SWOT Analysis

    List of Tables

    Table 01: Global Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 02: Global Transcatheter Embolization and Occlusion Devices Market Volume (Units) Forecast, by Product, 2017–2027

    Table 03: Global Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Coils, 2017–2027

    Table 04: Global Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Coiling-assist Devices, 2017–2027

    Table 05: Global Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Particles, 2017–2027

    Table 06: Global Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Accessories, 2017–2027

    Table 07: Global Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 08: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) Forecast, by End-user, 2017–2027

    Table 09: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) Forecast, by Region, 2017–2027

    Table 10: North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027

    Table 11: North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 12: North America Transcatheter Embolization and Occlusion Devices Market Volume (Units) Forecast, by Product, 2017–2027

    Table 13: North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Coils, 2017–2027

    Table 14: North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Coiling Assist Devices, 2017–2027

    Table 15: North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Particles, 2017–2027

    Table 16: North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Accessories, 2017–2027

    Table 17: North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 18: North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 19: Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 20: Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 21: Europe Transcatheter Embolization and Occlusion Devices Market Volume (Units) Forecast, by Product, 2017–2027

    Table 22: Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Coils, 2017–2027

    Table 23: Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Coiling Assist Devices, 2017–2027

    Table 24: Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Particles, 2017–2027

    Table 25: Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Accessories, 2017–2027

    Table 26: Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 27: Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 28: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 29: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 30: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Volume (Units) Forecast, by Product, 2017–2027

    Table 31: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Coils, 2017–2027

    Table 32: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Coiling-assist Devices, 2017–2027

    Table 33: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Particles, 2017–2027

    Table 34: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Accessories, 2017–2027

    Table 35: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 36: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 37: Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027

    Table 38: Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 39: Latin America Transcatheter Embolization and Occlusion Devices Market Volume (Units) Forecast, by Product, 2017–2027

    Table 40: Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Coils, 2017–2027

    Table 41: Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Coiling Assist Devices, 2017–2027

    Table 42: Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Particles, 2017–2027

    Table 43: Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Accessories, 2017–2027

    Table 44: Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 45: Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 46: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 47: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 48: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Volume (Units) Forecast, by Product, 2017–2027

    Table 49: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Coils, 2017–2027

    Table 50: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Coiling Assist Devices, 2017–2027

    Table 51: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Particles, 2017–2027

    Table 52: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Accessories, 2017–2027

    Table 53: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

    Table 54: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    List of Figure

    Figure 01: Global Transcatheter Embolization and Occlusion Devices Market Size (US$ Mn) and Distribution (%), by Region, 2018 and 2027

    Figure 02: Global Transcatheter Embolization and Occlusion Devices Market Value Share, by Product (2018)

    Figure 03: Global Transcatheter Embolization and Occlusion Devices Market Value Share, by Application (2018)

    Figure 04: Global Transcatheter Embolization and Occlusion Devices Market Value Share, by End-user (2018)

    Figure 05: Global Transcatheter Embolization and Occlusion Devices Market Value Share, by Region (2018)

    Figure 06: Global Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, 2017–2027

    Figure 07: Global Transcatheter Embolization and Occlusion Devices Market Value Share Analysis, by Product, 2018 and 2027

    Figure 08: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Embolization Coils, 2017–2027

    Figure 09: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Coiling-assist Devices, 2017–2027

    Figure 10: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Embolization Particles, 2017–2027

    Figure 11: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Flow Diverter Devices, 2017–2027

    Figure 12: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Liquid Embolics, 2017–2027

    Figure 13: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Accessories, 2017–2027

    Figure 14: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Pushable, 2017–2027

    Figure 15: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Detachable, 2017–2027

    Figure 16: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Stent-assisted Coiling, 2017–2027

    Figure 17: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Balloon-assisted Coiling, 2017–2027

    Figure 18: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Radioembolization Particles, 2017–2027

    Figure 19: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Microspheres, 2017–2027

    Figure 20: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Drug-eluting Beads, 2017–2027

    Figure 21: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Others, 2017–2027

    Figure 22: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Catheters, 2017–2027

    Figure 23: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Guide Wires, 2017–2027

    Figure 24: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Others, 2017–2027

    Figure 25: Global Transcatheter Embolization and Occlusion Devices Market Attractiveness Analysis, by Product, 2018–2026

    Figure 26: Global Transcatheter Embolization and Occlusion Devices Market Value Share Analysis, by Application, 2018 and 2027

    Figure 27: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Peripheral Vascular Disease, 2017–2027

    Figure 28: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, Neurology, by 2017–2027

    Figure 29: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, Oncology, by 2017–2027

    Figure 30: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, Urology, by 2017–2027

    Figure 31: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, Others, by 2017–2027

    Figure 32: Global Transcatheter Embolization and Occlusion Devices Market Attractiveness Analysis, by Application, 2018–2026

    Figure 33: Global Transcatheter Embolization and Occlusion Devices Market Value Share (%), by End-user, 2018 and 2027

    Figure 34: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2017–2027

    Figure 35: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ambulatory Surgical Centers (ASCs), 2017–2027

    Figure 36: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Clinics, 2017–2027

    Figure 37: Global Transcatheter Embolization and Occlusion Devices Market Attractiveness, by End-user, 2018–2026

    Figure 38: Global Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Region, 2018 and 2026

    Figure 39: Global Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Region, 2018–2026

    Figure 40: North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 41: North America Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Country, 2018 and 2027

    Figure 42: North America Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Country, 2018–2026

    Figure 43: North America Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Product, 2018 and 2027

    Figure 44: North America Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Product, 2018–2026

    Figure 45: North America Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Application, 2018 and 2027

    Figure 46: North America Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Application, 2018–2026

    Figure 47: North America Transcatheter Embolization and Occlusion Devices Market Value Share (%), by End-user, 2018 and 2027

    Figure 48: North America Transcatheter Embolization and Occlusion Devices Market Attractiveness, by End-user, 2018–2026

    Figure 49: Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 50: Europe Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Country, 2018 and 2027

    Figure 51: Europe Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Country/Sub-region, 2018–2026

    Figure 52: Europe Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Product, 2018 and 2027

    Figure 53: Europe Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Product, 2018–2026

    Figure 54: Europe Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Application, 2018 and 2027

    Figure 55: Europe Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Application, 2018–2026

    Figure 56: Europe Transcatheter Embolization and Occlusion Devices Market Value Share (%), by End-user, 2018 and 2027

    Figure 57: Europe Transcatheter Embolization and Occlusion Devices Market Attractiveness, by End-user, 2018–2026

    Figure 58: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 59: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Country/Sub-region, 2018 and 2027

    Figure 60: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Country/Sub-region, 2018–2026

    Figure 61: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Product, 2018 and 2027

    Figure 62: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Product, 2018–2026

    Figure 63: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Application, 2018 and 2027

    Figure 64: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Application, 2018–2026

    Figure 65: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value Share (%), by End-user, 2018 and 2027

    Figure 66: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Attractiveness, by End-user, 2018–2026

    Figure 67: Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 68: Latin America Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Country/sub-region, 2018 and 2027

    Figure 69: Latin America Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Country/sub-region, 2018–2026

    Figure 70: Latin America Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Product, 2018 and 2027

    Figure 71: Latin America Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Product, 2018–2026

    Figure 72: Latin America Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Application, 2018 and 2027

    Figure 73: Latin America Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Application, 2018–2026

    Figure 74: Latin America Transcatheter Embolization and Occlusion Devices Market Value Share (%), by End-user, 2018 and 2027

    Figure 75: Latin America Transcatheter Embolization and Occlusion Devices Market Attractiveness, by End-user, 2018–2026

    Figure 76: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 77: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Country/Sub-region, 2018 and 2027

    Figure 78: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Country/Sub-region, 2018–2026

    Figure 79: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Product, 2018 and 2027

    Figure 80: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Product, 2018–2026

    Figure 81: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Application, 2018 and 2027

    Figure 82: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Application, 2018–2026

    Figure 83: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value Share (%), by End-user, 2018 and 2027

    Figure 84: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Attractiveness, by End-user, 2018–2026

    Figure 85: Global Transcatheter Embolization and Occlusion Devices Market Analysis, by Top Company Ranking, 2018

Copyright © Transparency Market Research, Inc. All Rights reserved